Roubelakis MG - Search Results

1

Stem cells as potential targeted therapy for inflammatory bowel disease.

Gazouli M, Roubelakis MG, Theodoropoulos GE. Gazouli M, et al. Among authors: roubelakis mg. Inflamm Bowel Dis. 2014 May;20(5):952-5. doi: 10.1097/01.MIB.0000442922.85569.21. Inflamm Bowel Dis. 2014. PMID: 24572208 Review.

2

OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer.

Gazouli M, Roubelakis MG, Theodoropoulos GE, Papailiou J, Vaiopoulou A, Pappa KI, Nikiteas N, Anagnou NP. Gazouli M, et al. Among authors: roubelakis mg. Mol Carcinog. 2012 Feb;51(2):165-73. doi: 10.1002/mc.20773. Epub 2011 Apr 7. Mol Carcinog. 2012. PMID: 21480394

3

Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.

Bitsika V, Roubelakis MG, Zagoura D, Trohatou O, Makridakis M, Pappa KI, Marini FC, Vlahou A, Anagnou NP. Bitsika V, et al. Among authors: roubelakis mg. Stem Cells Dev. 2012 May 1;21(7):1097-111. doi: 10.1089/scd.2011.0151. Epub 2011 Oct 11. Stem Cells Dev. 2012. PMID: 21988169

4

Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.

Zagoura DS, Roubelakis MG, Bitsika V, Trohatou O, Pappa KI, Kapelouzou A, Antsaklis A, Anagnou NP. Zagoura DS, et al. Among authors: roubelakis mg. Gut. 2012 Jun;61(6):894-906. doi: 10.1136/gutjnl-2011-300908. Epub 2011 Oct 13. Gut. 2012. PMID: 21997562

5

Human amniotic fluid stem cells as an attractive tool for clinical applications.

Trohatou O, Anagnou NP, Roubelakis MG. Trohatou O, et al. Among authors: roubelakis mg. Curr Stem Cell Res Ther. 2013 Mar;8(2):125-32. doi: 10.2174/1574888x11308020003. Curr Stem Cell Res Ther. 2013. PMID: 23140502 Free article. Review.

6

Fetal mesenchymal stem cells in cancer therapy.

Bitsika V, Vlahou A, Roubelakis MG. Bitsika V, et al. Among authors: roubelakis mg. Curr Stem Cell Res Ther. 2013 Mar;8(2):133-43. doi: 10.2174/1574888x11308020004. Curr Stem Cell Res Ther. 2013. PMID: 23176305 Review.

7

Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.

Roubelakis MG, Tsaknakis G, Pappa KI, Anagnou NP, Watt SM. Roubelakis MG, et al. PLoS One. 2013;8(1):e54747. doi: 10.1371/journal.pone.0054747. Epub 2013 Jan 24. PLoS One. 2013. PMID: 23359810 Free PMC article.

8

Stem cells: insights into the secretome.

Makridakis M, Roubelakis MG, Vlahou A. Makridakis M, et al. Among authors: roubelakis mg. Biochim Biophys Acta. 2013 Nov;1834(11):2380-4. doi: 10.1016/j.bbapap.2013.01.032. Epub 2013 Jan 31. Biochim Biophys Acta. 2013. PMID: 23376432 Review.

9

Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis.

Legaki E, Roubelakis MG, Theodoropoulos GE, Lazaris A, Kollia A, Karamanolis G, Marinos E, Gazouli M. Legaki E, et al. Among authors: roubelakis mg. Stem Cell Rev Rep. 2016 Oct;12(5):604-612. doi: 10.1007/s12015-016-9677-1. Stem Cell Rev Rep. 2016. PMID: 27503204

10

miR-26a Mediates Adipogenesis of Amniotic Fluid Mesenchymal Stem/Stromal Cells via PTEN, Cyclin E1, and CDK6.

Trohatou O, Zagoura D, Orfanos NK, Pappa KI, Marinos E, Anagnou NP, Roubelakis MG. Trohatou O, et al. Among authors: roubelakis mg. Stem Cells Dev. 2017 Apr 1;26(7):482-494. doi: 10.1089/scd.2016.0203. Epub 2017 Feb 13. Stem Cells Dev. 2017. PMID: 28068868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters